IRF
MYGN icon

IBM Retirement Fund’s Myriad Genetics MYGN Stock Holding History

IBM Retirement Fund’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-17,749
Closed -$628K – 1055
2015
Q1 		$628K Hold
17,749
– – 0.01% 914
2014
Q4 		$605K Buy
17,749
+1,679
+10% +$59.6K 0.01% 921
2014
Q3 		$620K Sell
16,070
-2,113
-12% -$78.8K 0.01% 882
2014
Q2 		$712K Sell
18,183
-235
-1% -$8.74K 0.01% 900
2014
Q1 		$636K Sell
18,418
-10,836
-37% -$336K 0.01% 907
2013
Q4 		$613K Sell
29,254
-3,222
-10% -$81.5K 0.01% 973
2013
Q3 		$763K Sell
32,476
-4,438
-12% -$126K 0.01% 949
2013
Q2 		$992K Buy
+36,914
New +$1.07M 0.01% 919

Other funds holding MYGN

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IBM Retirement Fund's MYGN Position: Q2 2015 in Review

IBM Retirement Fund sold out of Myriad Genetics (MYGN) in Q2 2015, closing a stake of 17,749 shares — an estimated $628K sold.

IBM Retirement Fund first reported a position in MYGN in Q2 2013 and held it in 8 quarters. The position peaked at $992K in Q2 2013. 234 funds tracked by Wall St. Rank hold MYGN as of Q2 2015.

  • IBM Retirement Fund reported no remaining Myriad Genetics position as of Q2 2015 after selling out during the quarter.
  • IBM Retirement Fund sold 17,749 Myriad Genetics shares in Q2 2015, an estimated $628K.
  • IBM Retirement Fund first reported a position in Myriad Genetics in Q2 2013 and held it in 8 quarters.
  • IBM Retirement Fund's Myriad Genetics position peaked at $992K in Q2 2013.
  • 234 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2015.

Based on IBM Retirement Fund's 13F filing for Q2 2015, filed 27 Aug 2015.